Efficacy of Docetaxel 60 mg/m2 in Patients With Metastatic Breast Cancer According to the Status of Anthracycline Resistance

To evaluate the efficacy of docetaxel 60 mg/m2 in metastatic breast cancer (MBC) according to the status of anthracycline resistance. Ninety-nine patients with anthracycline-resistant MBC were treated with docetaxel 60 mg/m2 intravenously for a 90-minute period every 3 to 4 weeks. Anthracycline resi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical oncology 2001-01, Vol.19 (2), p.336-342
Hauptverfasser:	ANDO, Masashi, WATANABE, Toru, NAGATA, Kazuhiro, NARABAYASHI, Masaru, ADACHI, Isamu, KATSUMATA, Noriyuki
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antibiotics, Antineoplastic - therapeutic use Antineoplastic agents Antineoplastic Agents - administration & dosage Antineoplastic Agents - therapeutic use Biological and medical sciences Breast Neoplasms - drug therapy Breast Neoplasms - pathology Chemotherapy Drug Resistance, Neoplasm Female Humans Medical sciences Middle Aged Neoplasm Metastasis Paclitaxel - administration & dosage Paclitaxel - analogs & derivatives Paclitaxel - therapeutic use Pharmacology. Drug treatments Survival Analysis Taxoids Treatment Failure
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!